ClostraBio's Grant

ClostraBio raised a round of funding on June 01, 2017. Investors include University of Chicago.

ClostraBio is discovering and developing new therapeutics that modulate the protective ability of the microbiome. It is developing a drug that can prevent allergic reactions to food.…

Articles about ClostraBio's Grant: